Amd_2_FDA-RFQ-19-1213662.pdf

FDA‐RFQ‐19‐1213662

Amendment 2

FDA Cloud Interconnect Services and Support

The purpose of amendment 2 is to 1) Delete Attachment 1 Pricing Worksheet; 2) Add Amd 2 Attachment 1 Pricing Worksheet and 3) add answers to the Questions and Answer Session (Continuation from Amendment 1).

QUESTION 10: Attachment 1 Pricing Worksheet: for column G cell G12 header reads as "Monthly Recurring Cost" however based on the formula established it contemplates the number of months (cell F12) making its description inconsistent and it shall read "Annual Recurring Cost". Same applies for cell G24 since based on the formula from the file provided reflects it Sums the "Annual Recurring Cost" instead of "Monthly Recurring Cost". Would you amend agreeable to update this attachment and correct the header OR would you allow the Quoter to correct this typo and include under "Notes & Assumptions" tab? please confirm

Answer: Attachment 1 Pricing Worksheet is revised.

QUESTION 11: Attachment 2 SBSMP: ***** holds a pre-approved/vetted GSA Commercial Small Business Subcontracting Plan currently under SBA revision. Since we are checking the Commercial Box on section 1, page 2 from the Attachment 2, it reads to "stop here and attach a copy of your commercial plan".

Based on this scenario will still the signature block from page 7 required? please confirm

Answer: The agency this contract will be established with is the Food and Drug Administration (FDA).

Quoter may submit their approved FDA Commercial products/service plan or approved FDA Master Subcontracting Plan for Fiscal Year 2019.

This contract is not associated with GSA. GSA Commercial Small Business Subcontracting Plan may or may not meet the standard for the FDA for Fiscal Year 2019.

All Quoters shall certify and complete Signature Page on page 7.

End of Amendment